A propofol binding site on mammalian GABAA receptors identified by photolabeling


Propofol is the most important intravenous general anesthetic in current clinical use. It acts by potentiating GABAA (γ-aminobutyric acid type A) receptors, but where it binds to this receptor is not known and has been a matter of some debate. We synthesized a new propofol analog photolabeling reagent whose biological activity is very similar to that of propofol. We confirmed that this reagent labeled known propofol binding sites in human serum albumin that have been identified using X-ray crystallography. Using a combination of protiated and deuterated versions of the reagent to label mammalian receptors in intact membranes, we identified a new binding site for propofol in GABAA receptors consisting of both β3 homopentamers and α1β3 heteropentamers. The binding site is located within the β subunit at the interface between the transmembrane domains and the extracellular domain and lies close to known determinants of anesthetic sensitivity in the transmembrane segments TM1 and TM2.

DOI: 10.1038/nchembio.1340

Extracted Key Phrases

3 Figures and Tables

Citations per Year

434 Citations

Semantic Scholar estimates that this publication has 434 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@inproceedings{Yip2013APB, title={A propofol binding site on mammalian GABAA receptors identified by photolabeling}, author={Grace M S Yip and Zi-wei Chen and Christopher J. Edge and Edward H. Smith and Robert Dickinson and Erhard Hohenester and R. Reid Townsend and Karoline Fuchs and Werner Sieghart and Alex S Evers and Nicholas P Franks}, booktitle={Nature chemical biology}, year={2013} }